About Beacon Discovery
Beacon Discovery is a company based in San Diego (United States) founded in 2016 by Graeme Semple, Sunny Al Shamma, and Andrew Grottick was acquired by Eurofins Scientific in February 2021. The company has 34 employees as of December 31, 2022. Beacon Discovery operates in a competitive market with competitors including Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
- Headquarter San Diego, United States
- Employees 34 as on 31 Dec, 2022
- Founders Graeme Semple, Sunny Al Shamma, Andrew Grottick
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Beacon Discovery Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
34
as on Dec 31, 2022
-
Acquired by
Eurofins Scientific
(Feb 18, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Beacon Discovery
Detailed funding history for Beacon Discovery
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Beacon Discovery
Beacon Discovery has secured backing from 1 investor. Prominent investors backing the company include Eurofins Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Laboratory testing and contract research services are provided globally.
|
Locked | Locked | Locked |
Investor details for Beacon Discovery
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beacon Discovery
Investment portfolio details for Beacon Discovery
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Beacon Discovery
Detailed financials for Beacon Discovery
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beacon Discovery Comparisons
Peer comparison for Beacon Discovery
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Beacon Discovery
Beacon Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| Locked | Locked | Locked |
Instruments for automated molecular assays are developed using disposable cartridges.
|
|
| Locked | Locked | Locked |
Cell and gene therapies for multiple diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of a drug pipeline programs for neurodegenerative diseases
|
|
| Locked | Locked | Locked |
AI-based platform for drug discovery and antibody detection is provided.
|
|
| Locked | Locked | Locked |
Protein design, synthesis, testing, and validation services are offered.
|
Detailed competitors of Beacon Discovery
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beacon Discovery
Complete news archive for Beacon Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beacon Discovery
Beacon Discovery was founded in 2016.
Beacon Discovery is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Sunny Al Shamma is the current CEO of Beacon Discovery. They have also founded this company.
As of Dec 31, 2022, the latest employee count at Beacon Discovery is 34.
Beacon Discovery comprises of a team of GPCR experts who are working towards the development of GPCR based therapeutics. They have a broad range of high throughput and targeted assay platforms addressing emerging GPCR biology, The company currently focuses on CNS and GILiver disease areas, whilst exploring innovative pathway-directed and primary cell-based methodologies to uncover new GPCR-mediated approaches.
Beacon Discovery has 1 investor. Key investors include Eurofins Scientific.